Compare COSM & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COSM | TRIB |
|---|---|---|
| Founded | 2009 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9M | 18.6M |
| IPO Year | 2013 | N/A |
| Metric | COSM | TRIB |
|---|---|---|
| Price | $0.38 | $0.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 934.4K | 244.7K |
| Earning Date | 11-17-2025 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $59,792,819.00 | $48,570,000.00 |
| Revenue This Year | $20.69 | $13.51 |
| Revenue Next Year | $53.10 | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.69 | N/A |
| 52 Week Low | $0.28 | $0.48 |
| 52 Week High | $1.32 | $3.44 |
| Indicator | COSM | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 30.06 | 45.38 |
| Support Level | $0.35 | $0.78 |
| Resistance Level | $0.47 | $0.96 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 15.72 | 25.13 |
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.